Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP

Similar documents
Antifungal drugs Dr. Raz Muhammed

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Pharmaceutical Chemistry II. Antifungal Agents. = Antimycotics. Tutorial 1

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan

ANTIMYCOTIC DRUGS Modes of Action

Course content. Chemotherapeutic agents

Biochemical Targets for Antifungal Chemotherapy

Med Chem 401: Mycology ( Mycology

(Notes on Anti-TB agents are included in the TB syllabus)

PHARMACEUTICAL CHEMISTRY II (PHCM672) Lecture 1, Antifungal Drugs (Antimycotics) Dr. Mohammad Abdel-Halim

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6

ANTIFUNGAL AGENTS. Alison Clode, DVM, DACVO. Port City Veterinary Referral Hospital Portsmouth, New Hampshire

Biochemical Targets for Antifungal Chemotherapy

Management of fungal infection

Special features. For personal use only. Not to be reproduced without permission of the editor

Antifungal Drugs 35 I. OVERVIEW II. DRUGS FOR SUBCUTANEOUS AND SYSTEMIC MYCOTIC INFECTIONS

SUSCEPTIBILITY PROFILE OF EMERGING FUNGAL PATHOGENS

Current Options in Antifungal Pharmacotherapy

Antifungals, antivirals, antiprotozoals, and anthelmintics

Chapter III ANTIVIRAL AND ANTIFUNGAL DRUGS

Antifungal resistance mechanisms in pathogenic fungi

About the Editor Gerri S. Hall, Ph.D.

B. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.

THE TREATMENT OF MYCOSES IN REPTILES: A REVIEW OF ANTIFUNGAL DRUGS

Cigna Drug and Biologic Coverage Policy

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

Antifungal therapies differences in agents

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

Improving Clinical Outcomes in Fungal Infection Control and Management

Drugs dermatological conditions II

Medical Management of Fungal Sinusitis

Ali Alabbadi. Sarah Jaar ... Nader

MANAGEMENT OF PULMONARY MYCOSIS

number Done by Corrected by Doctor د.حامد الزعبي

Current and Emerging Azole Antifungal Agents

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Mycology. Dr. Agoston Ghidan

Pharmacogenomics of Antifungal Agents

Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis

LUZU (luliconazole) external cream

NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Common Fungi. Catherine Diamond MD MPH

DISEASES OF FUNGAL ORIGIN

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

Fungal infections and critically ill adults

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory ZODERM E CREAM. Oxiconazole Nitrate Cream

Sumyuktha J., Murali Narasimhan*, Parveen Basher Ahamed

Review article J Bas Res Med Sci 2018; 5(2):48-55.

Updates and practical guide on antifungal agents

Clinical Practice Guideline Superficial Fungal Infection

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

No Evidence As Yet. Georg Maschmeyer. Dept. of Hematology, Oncology & Palliative Care Klinikum Ernst von Bergmann Potsdam, Germany

Royce Johnson, M.D., F.A.C.P. Disclosure Information Research Support/Consultant/Speaker

Medicinal Chemistry I II nd Module Special Section (3) Major Antifungal Drugs

Fungal Infections. Alessandro Diana November 22th 2007

Malaria prevention: source = The Sanford Guide to Antimicrobial Therapy. Gilbert et al.

Antifungals and current treatment guidelines in pediatrics and neonatology

New antifungal agents

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

ITRANOX. Composition Each capsule contains :

Abbreviated Class Update: Topical Antifungal Agents. Month/Year of Review: September 2014 Date of Last Review: March 2014

Form 2046 R3.0: Fungal Infection Pre-HSCT Date

Current options of antifungal therapy in invasive candidiasis

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

Treatment of rare and emerging fungal infections. EFISG Educational Workshop 15 th ECCMID April 2, 2005, Copenhagen

Review Article Antifungal Resistance and New Strategies to Control Fungal Infections

C. albicans C. tropicalis C. parapsilosis C. kefyr C. glabrata C. krusei C. guillermondii C. lusitaniae THERAPY USING ANTIFUNGALS AND ANTIVIRALS

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

ANTIFUNGAL DRUG DISCOVERY: FOCUS ON INCRUSTOPORIN DERIVATIVES

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antibiotics 301: Antifungal Agents

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR

Naf tifine: A Topical Allylamine Antifungal Agent

Condition First line Alternative Comments Candidemia Nonneutropenic adults

IJBCP International Journal of Basic & Clinical Pharmacology

J. Hibler, D.O. OhioHealth - O Bleness Memorial Hospital, Athens, Ohio. AOCD Annual Conference Orlando, Florida

Antifungals and Anti-Tuberculosis Agents

Outline Dermatomycoses Definition: diseases or fungal infections of the skin Transmission of Dermatomycoses Case Report 1 Presentation of Disease

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Antifungals and Anti-Tuberculosis Agents

Dr Hamed Alzoubi. Fungal infections

Voriconazole. Voriconazole VRCZ ITCZ

TINEA (FUNGAL) INFECTION

Summary of Product Characteristics

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

البيض بالمبيضات الحفاظي الجلد التهاب = candidiasis Diaper

Challenges and controversies of Invasive fungal Infections

Pharmacology of Antifungal Drugs in Newborns- Rio de Janeiro August 2014

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

The incidence of invasive fungal infections

ESCMID Online Lecture Library. by author

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF

Trust Guideline for the Use of Antifungals in Adults

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi Medical Microbiology

How Can We Prevent Invasive Fungal Disease?

number Done by Corrected by Doctor

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Transcription:

Ústav farmakologie LF UP November 14, 2005

Introduction Polyens Azoles Alylamines Other Outline Introduction Polyens Azoles Alylamines and morfolines Other

Introduction Polyens Azoles Alylamines Other Mycoses Systemic mycoses systemic candidiasis cryptococal meningitis or endocarditis pulmonary aspergillosis rhinocerebral mucormycosis Superficial mycoses dermatomycoses (tinea) trichophyton microsporum epidermophyton superficial candidiasis aspergilloma tinea pedis

Introduction Polyens Azoles Alylamines Other Physiology membrane pores polyens cell wall reductase demethylase ergosterol demethyl lanosterol lanosterol ergosterol synthesis inhibitors morfolines: amorolfine azoles: ketoconazole epoxidase squalene epoxide squalene DNA/RNA alylamines: naftifine microtubules inhibitors griseofulvin antimetabolite fluorouracil flucytosine cytosindeaminase

Introduction Polyens Azoles Alylamines Other Polyens Introduction Polyens Azoles Alylamines and morfolines Other

Introduction Polyens Azoles Alylamines Other Polyens Amphotericin B antibiotic macrolide structure binds to ergosterol in membrane creates pores loss of K + combination with flucytosine Indications severe systemic mycoses amphotericin B candidosis(endocarditis, pneumonia, systemic candidosis) aspergillosis and mucormycoses drug of choice cryptococcocal infections, including meningitis coccidiomycosis, histoplasmosis, blastomycosis

Introduction Polyens Azoles Alylamines Other Polyens Amphotericin B Characteristics not absorbed from GIT fungistatic toxic lipid complexes, β cyclodextrin, liposomes, nanospheres normally does not cross BBB Side effects nephrotoxic renal impairment in 80% of patients hypokalaemia, hypomagnesaemia nausea, chills, fever, headache local reaction slow i.v. infusion

Introduction Polyens Azoles Alylamines Other Polyens Nystatin similar to Amphotericin B no absorption highly toxic only local Natamycin (pimaricin) similar to nystatin local therapy

Introduction Polyens Azoles Alylamines Other Azoles Introduction Polyens Azoles Alylamines and morfolines Other

Introduction Polyens Azoles Alylamines Other Physiology membrane pores polyens cell wall ergosterol ergosterol synthesis inhibitors reductase morfolines: amorolfine demethyl lanosterol demethylase lanosterol azoles: ketoconazole cell membrane epoxidase squalene epoxide squalene alylamines: naftifine microtubules inhibitors griseofulvin DNA/RNA antimetabolite fluorouracil flucytosine cytosindeaminase

Introduction Polyens Azoles Alylamines Other Azoles General characteristics & action synthetic fungistatic inhibit fungal CYP450 3A alter fluidity of membrane inhibit replication imidazoles and triazoes Indications topical use (some also have antibacterial activity) systemic use local and systemic mycoses clotrimazole

Introduction Polyens Azoles Alylamines Other Azoles Miconazole obsolete Ketoconazole first azole for oral administration Indications systemic candidosis, coccidiomycosis, histoplasmosis, skin mycosis Side effects nausea, vomiting, hepatopathy, inhibition of steroid hormones production Interactions CYP 3A, needs acid for absorption

Introduction Polyens Azoles Alylamines Other Azoles Fluconazole triazole reaches high concentrations in CSF can reach fungicidal concentrations Indications first choice for fungal meningitis Side effects better tolerated, GIT, does not inhibit steroids Interactions lower afinity to human CYP 3A

Introduction Polyens Azoles Alylamines Other Azoles Itraconazole triazole, lipid soluble variable absorption β cyclodextrin coated particles for IV Indications first choice for fungal meningitis Side effects well tolerated, skin lesions, does not inhibit steroids Interactions CYP 3A inhibition, needs acid (Coca Cola )

Introduction Polyens Azoles Alylamines Other Azoles other voriconazole wider spectrum more expensive (VFEND ) posaconazole even wider spectrum even more expensive (Noxafil ) ravuconazole in clinical trials

Introduction Polyens Azoles Alylamines Other Alylamines and morfolines Introduction Polyens Azoles Alylamines and morfolines Other

Introduction Polyens Azoles Alylamines Other Physiology membrane pores polyens cell wall reductase demethylase ergosterol demethyl lanosterol lanosterol ergosterol synthesis inhibitors morfolines: amorolfine azoles: ketoconazole epoxidase squalene epoxide squalene DNA/RNA alylamines: naftifine microtubules inhibitors griseofulvin antimetabolite fluorouracil flucytosine cytosindeaminase

Introduction Polyens Azoles Alylamines Other Alylamines and morfolines naftifine local, fingicidal, wide spectrum antiflogistic effect terbinafine similar to naftifine, also oral form, keratinophilic amorolfine good penetration into nails used in the form of a lacquer

Introduction Polyens Azoles Alylamines Other Other Introduction Polyens Azoles Alylamines and morfolines Other

Introduction Polyens Azoles Alylamines Other Physiology membrane pores polyens cell wall reductase demethylase ergosterol demethyl lanosterol lanosterol ergosterol synthesis inhibitors morfolines: amorolfine azoles: ketoconazole epoxidase squalene epoxide squalene DNA/RNA alylamines: naftifine microtubules inhibitors griseofulvin antimetabolite fluorouracil flucytosine cytosindeaminase

Introduction Polyens Azoles Alylamines Other Others griseofulvin local infections, given systemically obsolete, treatment needs to be very long flucytosine cytosindeaminase inhibitor (cytosine > uracil) good efect on candida 10g daily well tolerated, mild side effects beneficial combination with amphotericin B

Introduction Polyens Azoles Alylamines Other Others caspofungin inhibits cell wall synthesis wide spectrum poor oral absorption long half life 1 dose/day other pradimicin, nikkomycins sordarins GCSFs vaccines?

thank you for your attention